General MedicationsTOPICALStandard
ADAPALENE
ADAPALENE
Standard Dose
0.1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ADAPALENE is listed in Drugs@FDA under application 204593 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ADAPALENE Form and strength SOLUTION;TOPICAL - 0.1% Sponsor WAYLIS THERAP Submission history Latest submission status date: 2017-07-11 00:00:00.
Structured Monograph
Clinical summary
Approval overview ADAPALENE is listed in Drugs@FDA under application 204593 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ADAPALENE Form and strength SOLUTION;TOPICAL - 0.1% Sponsor WAYLIS THERAP Submission history Latest submission status date: 2017-07-11 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.